Top 4 Stocks In The Drugs-Generic Industry With The Highest Operating Margin

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Akorn

is 27.84%. Akorn's PEG ratio is 2.02. The trailing-twelve-month operating margin at Salix Pharmaceuticals

is 26.47%. Salix Pharmaceuticals' ROE for the same period is 17.90%. The trailing-twelve-month operating margin at Mylan

is 19.42%. Mylan's revenue for the same period is $6.82 billion. The trailing-twelve-month operating margin at Hi-Tech Pharmacal Co

is 15.88%. Hi-Tech Pharmacal had $108.28 million in total cash for the latest quarter.